Diverse childhood neurologic disorders and outcomes following fetal neurologic consultation [0.03%]
胎儿神经学咨询后的儿童神经发育障碍及预后状况
Dawn Gano,Andrea C Pardo,Orit A Glenn et al.
Dawn Gano et al.
Fetal neurology encompasses the full spectrum of neonatal and child neurology presentations, with complex additional layers of diagnostic and prognostic challenges unique to the specific prenatal consultation. Diverse genetic and acquired e...
Interdisciplinary fetal neurology care: Current practice, challenges, and future directions [0.03%]
跨学科的胎儿神经学护理:当前实践、挑战及未来方向
Charu Venkatesan,DonnaMaria Cortezzo,Mounira Habli et al.
Charu Venkatesan et al.
As the field of fetal-neonatal neurology has expanded over the past 2 decades with increasingly complex diagnoses, multidisciplinary collaboration with many subspecialties including genetics, neonatology, obstetrics, maternal fetal medicine...
Surfactant delivery by aerosol inhalation - past, present, and future [0.03%]
吸入性表面活性剂给药疗法:过去、现在和未来展望
Scott O Guthrie,J Jane Pillow,James J Cummings
Scott O Guthrie
Surfactant replacement therapy (SRT) by nebulization to spontaneously breathing patients has been regarded as the Holy Grail since surfactant deficiency was first identified as the cause for neonatal respiratory distress syndrome. It avoids...
Angela Kribs,Kari D Roberts,Daniele Trevisanuto et al.
Angela Kribs et al.
Non-invasive modes of respiratory support have been shown to be the preferable way of primary respiratory support of preterm infants with respiratory distress syndrome (RDS). The avoidance of invasive mechanical ventilation can be beneficia...
Surfactant and neonatal hemodynamics during the postnatal transition [0.03%]
表面活性剂与新生儿出生后的血液循环变化之间的关系
Sanoj Km Ali,Amy H Stanford,Patrick J McNamara et al.
Sanoj Km Ali et al.
Surfactant replacement therapy (SRT) has revolutionized the management of respiratory distress syndrome (RDS) in premature infants, leading to improved survival rates and decreased morbidity. SRT may, however, be associated with hemodynamic...
Neonatal surfactant therapy beyond respiratory distress syndrome [0.03%]
用于治疗新生儿呼吸窘迫综合征以外疾病的表面活性物质疗法
Peter A Dargaville,Egbert Herting,Roger F Soll
Peter A Dargaville
Whilst exogenous surfactant therapy is central to the management of newborn infants with respiratory distress syndrome, its use in other neonatal lung diseases remains inconsistent and controversial. Here we discuss the evidence and experie...
Arun Sett,Charles C Roehr,Brett J Manley
Arun Sett
Drug delivery using a surfactant vehicle has the potential to prevent systemic side effects by delivering therapeutic agents directly to the respiratory system. The inherent chemical properties of surfactant allows it to readily distribute ...
Synthetic surfactants [0.03%]
合成表面活性剂
Fernando Moya,Tore Curstedt,Jan Johansson et al.
Fernando Moya et al.
Towards personalized therapies for genetic disorders of surfactant dysfunction [0.03%]
向遗传性肺表面活性剂功能障碍的个性化治疗迈进
Maureen Peers de Nieuwburgh,Jennifer A Wambach,Matthias Griese et al.
Maureen Peers de Nieuwburgh et al.
Genetic disorders of surfactant dysfunction are a rare cause of chronic, progressive or refractory respiratory failure in term and preterm infants. This review explores genetic mechanisms underpinning surfactant dysfunction, highlighting sp...
Sandy Kirolos,Gemma Edwards,Joyce OShea
Sandy Kirolos
Endotracheal intubation is a life-saving procedure for many newborns. Historically, it has been achieved by obtaining an airway view through the mouth via direct laryngoscopy. It is a skill that takes time and practice to achieve proficienc...